SANUWAVE Health, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 30, 2026 | Roth Capital | reiterate | Buy → Buy | — | 53% |
| Sep 3, 2025 | Northland Capital Markets | initiate | — → Outperform | $55 | 50% |
| Aug 22, 2025 | Roth Capital | maintain | Buy → Buy | $55 | 53% |
| Jul 29, 2025 | Roth Capital | initiate | — → Buy | $49 | 53% |
| Sep 15, 2020 | Lake Street | initiate | — → Buy | $0.34 | 47% |
No cross-platform signals in the last 90 days